Table 5 Summary statistics of the mixed regression models investigating baseline BRSK2 and ADCYAP1 methylation as predictors of change in posttraumatic stress symptoms scores over time.
Model | ß | Std error | t | p | 95% CI | ||
|---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Baseline BRSK2 CpG3 methylation | |||||||
1A | Baseline × CpG3 (baseline) | 0.07 | 0.10 | 0.71 | 0.482 | −0.13 | 0.27 |
3-months × CpG3 (baseline) | −0.39 | 0.10 | −3.81 | 0.0002* | −0.60 | −0.19 | |
6-months × CpG3 (baseline) | −0.49 | 0.10 | −4.76 | 0.000004* | −0.70 | −0.29 | |
1B | Baseline × CpG3 (baseline) | −0.12 | 0.10 | −1.17 | 0.247 | −0.33 | 0.08 |
3-months × CpG3 (baseline) | −0.16 | 0.15 | −1.09 | 0.276 | −0.45 | 0.13 | |
6-months × CpG3 (baseline) | −0.12 | 0.15 | −0.81 | 0.418 | −0.41 | 0.17 | |
Baseline × childhood trauma | 1.54 | 0.49 | 3.13 | 0.002* | 0.57 | 2.51 | |
3-months × childhood trauma | 1.21 | 0.66 | 1.84 | 0.069 | −0.09 | 2.52 | |
6-months × childhood trauma | −035 | 0.66 | −0.53 | 0.598 | −1.65 | 0.96 | |
Baseline × alcohol consumption | −1.36 | 0.76 | −1.79 | 0.077 | −2.87 | 0.15 | |
3-months × alcohol consumption | −0.96 | 1.23 | −0.78 | 0.438 | −3.40 | 1.48 | |
6-months × alcohol consumption | −1.65 | 1.23 | −1.35 | 0.181 | −4.09 | 0.78 | |
Baseline × depression | 0.73 | 0.14 | 5.29 | 0.0000008* | 0.46 | 1.01 | |
3-months × depression | 0.00 | 0.22 | 0.00 | 1.00 | −0.45 | 0.45 | |
6-months × depression | 0.49 | 0.22 | 2.19 | 0.031* | 0.05 | 0.93 | |
1C | Baseline × CpG3 (baseline) | −0.10 | 0.10 | −1.01 | 0.314 | −0.31 | 0.10 |
3-months × CpG3 (baseline) | −0.15 | 0.15 | −1.03 | 0.305 | −0.44 | 0.14 | |
6-months × CpG3 (baseline) | −0.10 | 0.15 | −0.68 | 0.496 | −0.39 | 0.19 | |
Baseline × childhood trauma | 1.12 | 0.52 | 2.45 | 0.016* | 0.24 | 2.30 | |
3-months × childhood trauma | 1.12 | 0.73 | 1.54 | 0.126 | −0.32 | 2.56 | |
6-months × childhood trauma | −0.67 | 0.72 | −0.93 | 0.355 | −2.10 | 0.76 | |
Baseline × alcohol consumption | −1.40 | 0.76 | −1.85 | 0.067 | −2.90 | 0.10 | |
3-months × alcohol consumption | −0.98 | 1.24 | −0.79 | 0.432 | −3.43 | 1.48 | |
6-months × alcohol consumption | −1.70 | 1.23 | −1.38 | 0.170 | −4.13 | 0.73 | |
Baseline × depression | 0.77 | 0.14 | 5.50 | 0.0000003* | 0.49 | 1.04 | |
3-months × depression | 0.01 | 0.23 | 0.06 | 0.952 | −0.44 | 0.47 | |
6-months × depression | 0.53 | 0.23 | 2.35 | 0.021* | 0.08 | 0.98 | |
Baseline × lifetime trauma | 2.06 | 1.36 | 1.51 | 0.134 | −0.65 | 4.76 | |
3-months × lifetime trauma | 0.79 | 2.24 | 0.35 | 0.727 | −3.66 | 5.23 | |
6-months × lifetime trauma | 2.47 | 2.22 | 1.11 | 0.270 | −1.95 | 6.88 | |
Baseline BRSK2 CpG4 methylation | |||||||
2A | Baseline × CpG4 (baseline) | 0.07 | 0.11 | 0.59 | 0.558 | −0.16 | 0.29 |
3-months × CpG4 (baseline) | −0.33 | 0.12 | −2.85 | 0.005* | −0.56 | −0.10 | |
6-months × CpG4 (baseline) | −0.44 | 0.12 | −3.83 | 0.0002* | −0.67 | −0.21 | |
2B | Baseline × CpG4 (baseline) | −0.08 | 0.12 | −0.70 | 0.486 | −0.31 | 0.15 |
3-months × CpG4 (baseline) | −0.14 | 0.15 | −0.93 | 0.357 | −0.44 | 0.16 | |
6-months × CpG4 (baseline) | −0.19 | 0.15 | −1.29 | 0.201 | −0.49 | 0.10 | |
Baseline × childhood trauma | 1.44 | 0.51 | 2.84 | 0.005* | 0.43 | 2.44 | |
3-months × childhood trauma | 1.20 | 0.70 | 1.73 | 0.086 | −0.17 | 2.58 | |
6-months × childhood trauma | −0.09 | 0.69 | −0.12 | 0.902 | −1.45 | 1.28 | |
Baseline × alcohol consumption | −1.41 | 0.77 | −1.84 | 0.069 | −2.93 | 0.11 | |
3-months × alcohol consumption | −1.00 | 1.23 | −0.81 | 0.421 | −3.44 | 1.45 | |
6-months × alcohol consumption | −1.60 | 1.22 | −1.32 | 0.191 | −4.02 | 0.82 | |
Baseline × depression | 0.71 | 0.14 | 5.08 | 0.000002* | 0.43 | 0.98 | |
3-months × depression | −0.01 | 0.23 | −0.05 | 0.963 | −0.46 | 0.44 | |
6-months × depression | 0.53 | 0.22 | 2.40 | 0.018* | 0.09 | 0.98 | |
2C | Baseline × CpG4 (baseline) | −0.04 | 0.12 | −0.36 | 0.720 | −0.27 | 0.19 |
3-months × CpG4 (baseline) | −0.12 | 0.16 | −0.75 | 0.458 | −0.42 | 0.19 | |
6-months × CpG4 (baseline) | −0.16 | 0.15 | −1.01 | 0.314 | −0.46 | 0.15 | |
Baseline × childhood trauma | 1.20 | 0.53 | 2.24 | 0.027* | 0.14 | 2.25 | |
3-months × childhood trauma | 1.17 | 0.77 | 1.53 | 0.130 | −0.35 | 2.69 | |
6-months × childhood trauma | −0.34 | 0.76 | −0.45 | 0.654 | −1.84 | 1.16 | |
Baseline × alcohol consumption | −1.47 | 0.76 | −1.93 | 0.056 | −2.99 | 0.04 | |
3-months × alcohol consumption | −1.03 | 1.24 | −0.83 | 0.407 | −3.49 | 1.43 | |
6-months × alcohol consumption | −1.67 | 1.22 | −1.37 | 0.175 | −4.09 | 0.75 | |
Baseline × depression | 0.74 | 0.14 | 5.28 | 0.0000008* | 0.46 | 1.02 | |
3-months × depression | 0.00 | 0.23 | 0.01 | 0.996 | −0.45 | 0.46 | |
6-months × depression | 0.57 | 0.22 | 2.52 | 0.013* | 0.12 | 1.01 | |
Baseline × lifetime trauma | 2.11 | 1.39 | 1.52 | 0.132 | −0.65 | 4.88 | |
3-months × lifetime trauma | 0.71 | 2.27 | 0.32 | 0.753 | −3.79 | 5.22 | |
6-months × lifetime trauma | 2.19 | 2.23 | 0.98 | 0.329 | −2.24 | 6.62 | |
Baseline BRSK2 CpG5 methylation | |||||||
3A | Baseline × CpG5 (baseline) | 0.16 | 0.10 | 1.60 | 0.112 | −0.04 | 0.35 |
3-months × CpG5 (baseline) | −0.27 | 0.10 | −2.66 | 0.009* | −0.47 | −0.07 | |
6-months × CpG5 (baseline) | −0.38 | 0.10 | −3.73 | 0.0003* | −0.58 | −0.18 | |
3B | Baseline × CpG5 (baseline) | −0.06 | 0.10 | −0.57 | 0.573 | −0.25 | 0.14 |
3-months × CpG5 (baseline) | −0.12 | 0.14 | −0.84 | 0.405 | −0.39 | 0.16 | |
6-months × CpG5 (baseline) | −0.06 | 0.14 | −0.44 | 0.657 | −0.33 | 0.21 | |
Baseline × childhood trauma | 1.60 | 0.50 | 3.21 | 0.002* | 0.61 | 2.58 | |
3-months × childhood trauma | 1.33 | 0.66 | 2.01 | 0.047* | 0.02 | 2.65 | |
6-months × childhood trauma | −0.27 | 0.66 | −0.41 | 0.683 | −1.58 | 1.04 | |
Baseline × alcohol consumption | −1.44 | 0.77 | −1.88 | 0.064 | −2.96 | 0.08 | |
3-months × alcohol consumption | −1.01 | 1.23 | −0.82 | 0.412 | −3.46 | 1.43 | |
6-months × alcohol consumption | −1.72 | 1.23 | −1.41 | 0.163 | −4.16 | 0.71 | |
Baseline × depression | 0.72 | 0.14 | 5.13 | 0.000002* | 0.44 | 1.00 | |
3-months × depression | 0.00 | 0.23 | 0.01 | 0.991 | −0.45 | 0.45 | |
6-months × depression | 0.48 | 0.22 | 2.14 | 0.035* | 0.03 | 0.93 | |
3C | Baseline × CpG5 (baseline) | −0.03 | 0.10 | −0.29 | 0.774 | −0.23 | 0.17 |
3-months × CpG5 (baseline) | −0.10 | 0.14 | −0.71 | 0.477 | −038 | 0.18 | |
6-months × CpG5 (baseline) | −0.03 | 0.14 | −0.22 | 0.827 | −0.31 | 0.25 | |
Baseline × childhood trauma | 1.34 | 0.53 | 2.56 | 0.012* | 0.30 | 2.39 | |
3-months × childhood trauma | 1.28 | 0.73 | 1.74 | 0.085 | −0.18 | 2.73 | |
6-months × childhood trauma | −0.58 | 0.73 | −0.80 | 0.425 | −2.03 | 0.86 | |
Baseline × alcohol consumption | −1.49 | 0.76 | −1.96 | 0.054 | −3.01 | 0.02 | |
3-months × alcohol consumption | −1.04 | 1.24 | −0.84 | 0.402 | −3.50 | 1.41 | |
6-months × alcohol consumption | −1.78 | 1.22 | −1.46 | 0.148 | −4.21 | 0.65 | |
Baseline × depression | 0.75 | 0.14 | 5.33 | 0.0000007* | 0.47 | 1.03 | |
3-months × depression | 0.01 | 0.23 | 0.06 | 0.950 | −0.44 | 0.47 | |
6-months × depression | 0.52 | 0.23 | 2.29 | 0.024* | 0.07 | 0.97 | |
Baseline × lifetime trauma | 2.12 | 1.39 | 1.53 | 0.129 | −0.63 | 4.88 | |
3-months × lifetime trauma | 0.74 | 2.26 | 0.33 | 0.75 | −3.74 | 5.22 | |
6-months × lifetime trauma | 2.52 | 2.23 | 1.13 | 0.262 | −1.92 | 6.96 | |
Baseline ADCYAP1 CpG1&2 methylation | |||||||
4A | Baseline × CpG1&2 (baseline) | 5.34 | 1.02 | 5.26 | 0.0000009* | 3.33 | 7.36 |
3-months × CpG1&2 (baseline) | −1.03 | 1.12 | −0.92 | 0.360 | −3.25 | 1.19 | |
6-months × CpG1&2 (baseline) | −3.52 | 1.18 | −2.97 | 0.004* | −5.86 | −1.17 | |
4B | Baseline × CpG1&2 (baseline) | −0.73 | 0.88 | −0.83 | 0.407 | −2.47 | 1.01 |
3-months × CpG1&2 (baseline) | 2.75 | 1.39 | 1.98 | 0.050 | −0.00 | 5.50 | |
6-months × CpG1&2 (baseline) | 1.66 | 1.39 | 1.20 | 0.235 | −1.10 | 4.41 | |
Baseline × childhood trauma | 1.84 | 0.47 | 3.95 | 0.0001* | 0.92 | 2.76 | |
3-months × childhood trauma | 1.11 | 0.59 | 1.88 | 0.062 | −0.05 | 2.26 | |
6-months × childhood trauma | −0.29 | 0.59 | −0.49 | 0.625 | −1.45 | 0.87 | |
Baseline × alcohol consumption | −1.48 | 0.77 | −1.93 | 0.057 | −3.01 | 0.05 | |
3-months × alcohol consumption | −1.43 | 1.22 | −1.18 | 0.242 | −3.85 | 0.98 | |
6-months × alcohol consumption | −1.91 | 1.21 | −1.57 | 0.120 | −4.32 | 0.51 | |
Baseline × depression | 0.73 | 0.14 | 5.29 | 0.0000008* | 0.46 | 1.01 | |
3-months × depression | −0.13 | 0.22 | −0.59 | 0.554 | −0.56 | 0.30 | |
6-months × depression | 0.42 | 0.22 | 1.96 | 0.052 | −0.00 | 0.85 | |
4C | Baseline × CpG1&2 (baseline) | −0.54 | 0.89 | −0.61 | 0.541 | −2.30 | 1.22 |
3-months × CpG1&2 (baseline) | 2.76 | 1.42 | 1.95 | 0.055 | −0.05 | 5.57 | |
6-months × CpG1&2 (baseline) | 1.59 | 1.41 | 1.13 | 0.263 | −1.22 | 4.40 | |
Baseline × childhood trauma | 1.87 | 0.47 | 4.01 | 0.0001* | 0.95 | 2.80 | |
3-months × childhood trauma | 1.06 | 0.59 | 1.79 | 0.076 | −0.11 | 2.24 | |
6-months × childhood trauma | −0.36 | 0.59 | −0.60 | 0.550 | −1.53 | 0.82 | |
Baseline × alcohol consumption | −1.44 | 0.76 | −1.88 | 0.063 | −2.96 | 0.08 | |
3-months × alcohol consumption | −1.43 | 1.22 | −1.17 | 0.247 | −3.86 | 1.01 | |
6-months × alcohol consumption | −1.91 | 1.22 | −1.56 | 0.121 | −4.34 | 0.52 | |
Baseline × depression | 0.74 | 0.14 | 5.33 | 0.0000006* | 0.46 | 1.01 | |
3-months × depression | −0.13 | 0.22 | −0.61 | 0.546 | −0.56 | 0.30 | |
6-months × depression | 0.42 | 0.22 | 1.92 | 0.058 | −0.01 | 0.85 | |
Baseline × HIV status | −4.51 | 3.54 | −1.27 | 0.206 | −11.55 | 2.53 | |
3-months × HIV status | −0.39 | 5.65 | −0.07 | 0.945 | −11.61 | 10.84 | |
6-months × HIV status | 1.24 | 5.65 | 0.22 | 0.827 | −9.99 | 12.46 | |